Quest for timely detection and treatment of women with depression

Journal of Managed Care Pharmacy

Volumn 13, Issue 9 SUPPL. A, 2007, Pages

  Alexander, Jeanne Leventhal ^a,b,c  

^a KAISER PERMANENTE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Alexander Foundation for Women's Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ANXIETY DISORDER; ARTICLE; CHILD SEXUAL ABUSE; CLIMACTERIUM; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE COURSE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; FEMALE; GENDER; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEREDITY; HUMAN; INJURY; LIFE EVENT; LIFE STRESS; MAJOR DEPRESSION; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD DISORDER; PATIENT CARE; PREGNANCY; PREVALENCE; PUBLIC HEALTH; PUERPERIUM; REMISSION; RISK ASSESSMENT; SEASONAL VARIATION; SOCIAL SUPPORT;

EID: 38149141477     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.9-a.3     Document Type: Article

References (134)

1. Kouzis AC, Eaton WW. Emotional disability days: prevalence and predictors. Am J Public Health. 1994;84(8):1304-07.
2. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262(7):914-19.
3. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29(2-3):85-96.
4. National Institute of Mental Health. The impact of mental illness on society. Available at: http://masterdocs.com/fact_sheet_files/pdf/ mental_illness.pdf. Accessed June 3, 2007.
5. Ohayon M, Schatzberg A. Fine-tuning our diagnosis and treatment of depression. Editorial. J Psychiatr Res. 2006;40(4):281-82.
6. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569-80.
7. Rentsch D, Dumont P, Borgacci S, et al. Prevalence and treatment of depression in a hospital department of internal medicine. Gen Hosp Psychiatry. 2007;29:25-31.
8. Grypma L, Haverkamp R, Little S, Unutzer J. Taking an evidence-based model of depression care from research to practice: making lemonade out of depression. Gen Hosp Psychiatry. 2006;28:101-07.
9. Parker G, Hadzi-Pavlovic D. Is the female preponderance in major depression secondary to a gender difference in specific anxiety disorders? Psychol Med. 2004;34:461-70.
10. Piccinelli M, Wilkinson G. Gender differences in depression. Critical review. Br J Psychiatry. 2000;177:486-92.
11. Wilhelm K, Roy K, Mitchell P, et al. Gender differences in depression risk and coping factors in a clinical sample. Acta Psychiatr Scand. 2002;106:45-53.
12. Gladstone GL, Parker GB, Mitchell PB, Malhi GS, Wilhelm K, Austin MP. Implications of childhood trauma for depressed women: an analysis of pathways from childhood sexual abuse to deliberate self-harm and revictimization. Am J Psychiatry. 2004;161:1417-25.
13. Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry. 2006;163:109-14.
14. Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr Scand. 2003;108:163-74.
15. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Women's Health. 2006;15:57-69.
16. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive development model for major depression in women. Am J Psychiatry. 2002;159:1133-45.
17. Orstavik RE, Kendler KS, Czajkowski N, Tambs K, Reichborn-Kjennerud T. Genetic and environmental contributions to depressive personality disorder in a population-based sample of Norwegian twins. J Affect Disord. 2007;99:181-89.
18. Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry. 2004;161:631-36.
19. Kendler KS, Kuhn JW, Prescott CA. Childhood sexual abuse, stressful life events, and risk of major depression in women. Psychol Med. 2004;34:1475-82.
20. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62-70.
21. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a five-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49:809-16.
22. Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry. 1998;44:348-60.
23. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-105.
24. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry. 2001;158:582-86.
25. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry. 2000; 157:1243-51.
26. Corruble E, Falissard B, Gorwood P. Life events exposure before a treated major depressive episode depends on the number of past episodes. Eur Psychiatry. 2006;21(6):364-66.
27. Kendler KS, Gardner CO, Gatz M, Pedersen NL. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med. 2007;37:453-62.
28. Bouma EM, Ormel J, Verhulst FC, Oldehinkel AJ. Stressful life events and depressive problems in early adolescent boys and girls: the influence of parental depression, temperament and family environment. J Affective Disord. June 13, 2007. Epub ahead of print.
29. Cervilla J, Molina E, Rivera M, et al. The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry. Advance online publication; March 27, 2007. Available at: www.nature.com/mp/journal/v12/n8/pdf/4001981a.pdf.
30. Kim J, Stewart R, Kim S, et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry. May 3, 2007;62(5):423-28. Epub ahead of print.
31. Stein M, Schork N, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. Advance online publication; April 25, 2007.
32. Kaufman J, Yang B-Z, Douglas-Palumberi H, et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry. 2006;59:673-80.
33. Wichers MC, Myin-Germeys I, Jacobs N, et al. Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study. Acta Psychiatr Scand. 2007;115(6):451-57.
34. Safford SM, Alloy LB, Abramson LY, Crossfield AG. Negative cognitive style as a predictor of negative life events in depression-prone individuals: a test of the stress generation hypothesis. J Affect Disorder. 2007;99:147-54.
35. Kendler K, Thornton L, Prescott C. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry. 2001;158:587-93.
36. Reichenberg A, Maccabe J. Feeling the pressure: work stress and mental health. Psychol Med. May 3, 2007;1:1-2. Epub ahead of print.
37. Santavirta N, Solovieva S, Theorell T. The association between job strain and emotional exhaustion in a cohort of 1,028 Finnish teachers. Br J Educ Psychol. 2007;77(pt 1):213-28.
38. Melchior M, Berkman N, Niedhammer I, Zins M, Goldberg M. The mental health effects of multiple work and family demands. A prospective study of psychiatric sickness absence in the French GAZEL study. Soc Psychiatry Psychiatr Epidemiol. May 24, 2007;42(7):573-82. Epub ahead of print.
39. Maclean H, Glynn K, Ansara D. Multiple roles and women's mental health in Canada. BMC Women's Health. 2004;4(suppl 1):S3-S7.
40. Greenberg P, Leong SA, Birnbaum H. Costs of depression: current assessment and future directions. Expert Rev Pharmacoeconomics Outcomes Res. 2001;1:69-76.
41. Kim-Cohen J, Moffitt TE, Taylor A, Pawlby SJ, Caspi A. Maternal depression and children's antisocial behavior. Arch Gen Psychiatry. 2005;62:173-81.
42. Remick R. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002;167:1253-60.
43. VonKorff M, Katon W, Unutzer J, Wells K, Wagner E. Improving depression care barriers, solutions, and research needs. J Fam Pract. 2001;50:530-31.
44. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289:3145-51.
45. Wells K, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283:212-20.
46. Paykel E. Cognitive therapy in relapse prevention in depression. Int J Neuropsychopharmacol. 2006;20:1-6.
47. Rush A, Kraemer H, Sackeim H, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841-53.
48. Thase ME, Friedman ES, Biggs MM, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007; 164:739-52.
49. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179-200.
50. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25:1171-80.
51. Keller MB. Past, present and future directions for defining optimal treatment outcome in depression. JAMA. 2003;289:3152-60.
52. Keller MB, Kocsis JH, Thase ME, et al. Maintenance phase efficacy of sertraline for chronic depression. JAMA. 1998;280:1665-72.
53. Kocsis JH, Schatzberg A, Rush J, et al. Psychosocial outcomes following long-term, double blind treatment of chronic depression with sertraline vs placebo. Arch Gen Psychiatry. 2002;59:723-28.
54. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder, 2nd ed. April 2000. In: American Psychiatric Association, Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2004. Arlington, VA: American Psychiatric Association; 2004.
55. Wisniewski SR, Fava M, Trivedi MH, et al. Acceptability of second-step treatments to depressed outpatients: a STAR*D report. Am J Psychiatry. 2007;164:753-60.
56. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231-42.
57. Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol. 2006;57:285-315.
58. Teasdale JD, Segal ZV, Williams JM, et al. Prevention of relapse/ recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68(4):615-23.
59. Fresco DM, Segal ZV, Buis T, Kennedy S. Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. J Consult Clin Psychol. 2007;75:447-55.
60. Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive behavioral therapy's effects. J Consult Clin Psychol. 2007;75:475-88.
61. Jarrett RB, Vittengl JR, Doyle K, Clark LA. Changes in cognitive content during and following cognitive therapy for recurrent depression: substantial and enduring, but not predictive of change in depressive symptoms. J Consult Clin Psychol. 2007;75:432-46.
62. Kingston T, Dooley B, Bates A, Lawlor E, Malone K. Mindfulness-based cognitive therapy for residual depressive symptoms. Psychol Psychother. 2007;80(pt 2):193-203.
63. Kashner TM, Henley SS, Golden RM, Rush AJ, Jarrett RB. Assessing the preventive effects of cognitive therapy following relief of depression: a methodological innovation. J Affect Disord. May 15, 2007. Epub ahead of print.
64. Segal ZV, Kennedy S, Gemar M, et al. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Arch Gen Psychiatry. 2006;63:749-55.
65. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington DC: American Psychiatric Association; 2000.
66. Bhatia SC, Bhatia SK. Depression in women: diagnostic and treatment considerations. Am Fam Physician. 1999;60:225-40.
67. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J. Longitudinal trajectories of depression and anxiety in a prospective community study. Arch Gen Psychiatry. 2003;60:993-1000.
68. Stewart W, Ricci J, Chee E, Hahn S, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135-44.
69. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329-35.
70. Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774-97.
71. Rowe SK, Rapaport MH. Classification and treatment of sub-threshold depression. Current Opinion in Psychiatry. 2006;19:9-13.
72. Jaffe A, Froom J, Galambos N. Minor depression and functional impairment. Arch Fam Med. 1994;3:1081-86.
73. Rapaport MH, Judd LL, Schettler PJ, et al. A descriptive analysis of minor depression. Am J Psychiatry. 2002;159:637-43.
74. Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord. 2004;79:71-79.
75. Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand. 2004;109:325-331.
76. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
77. Keller MB, Klein DN, Hirschfeld RM, et al. Results of the DSM-IV mood disorders field trial. Am J Psychiatry. 1995;152:843-49.
78. Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry. 2006;163:872-80.
79. Markowitz JC, Moran ME, Kocsis JH, Frances AJ. Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord. 1992;24:63-71.
80. Wittchen HU, Kessler RC, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatrica Scandinavica, Supplementum. 2000;406:14-23.
81. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35:1747-59.
82. Kessler RC, Keller MB, Wittchen HU. The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001;24:19-39.
83. Fricchione G. Generalized anxiety disorder. N Engl J Med. 2004;351:675-82.
84. Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy. JAMA. 1999;282:1264-69.
85. Hendrick V, Altshuler L, Strouse J, Grosser S. Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety. 2000;11:66-72.
86. Dennis CL. Psychosocial and psychological interventions for prevention of postnatal depression: systematic review. BMJ. 2005;331:15-23.
87. Bernstein IH, Rush AJ, Yonkers K, et al. Symptom features of postpartum depression: are they distinct? Depress Anxiety. 2006;1-7.
88. DeJong R, Rubinow DR, Roy-Byrne P, et al. Premenstrual mood disorder and psychiatric illness. Am J Psychiatry. 1985;142:1359-61.
89. Endicott J. The menstrual cycle and mood disorders. J Affect Disord. 1993;29:193-200.
90. Stout A, Steege J, Blazer D, George L. Comparison of lifetime psychiatric diagnoses in premenstrual syndrome clinic and community samples. J Nerv Ment Dis. 1986;174:517-22.
91. Yonkers K. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry. 1997;58:19-25.
92. Kim DR, Gyulai L, Freeman EW, Morrison MF, Baldassano C, Dubé B. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health. 2004;7:37-47.
93. Richards M, Rubinow D, Daly R, Schmidt P. Premenstrual symptoms and perimenopausal depression. Am J Psychiatry. 2006;163:133-37.
94. Levitt A, Boyle MH, Joffe RT, Baumal Z. Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample. Can J Psychiatry. 2000;45:650-54.
95. Levitt AJ, Boyle MH. The impact of latitude on the prevalence of seasonal depression. Can J Psychiatry. 2002;47:361-67.
96. Blazer D, Kessler R, Swartz M. Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. Br J Psychiatry. 1998;172:164-67.
97. Praschak-Rieder N, Willeit M, Neumeister A, et al. Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. J Affect Disord. 2001;63:239-42.
98. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry. 2004;161:2238-44.
99. Schmidt PJ, Murphy JH, Haq N, Rubinow DR, Danaceau MA. Stressful life events, personal losses, and perimenopause-related depression. Arch Womens Ment Health. 2004;7:19-26.
100. Cohen L, Soares C, Vitonis A, Otto M, Harlow B. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385-90.
101. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63:375-82.
102. Woods NF, Mariella A, Mitchell ES. Patterns of depressed mood across the menopausal transition: approaches to studying patterns in longitudinal data. Acta Obste. Gynecol Scan. 2002;81:623-32.
103. Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas. 1986;8(3):217-28.
104. Hunter M. The south-east England longitudinal study of the climacteric and postmenopause. Maturitas. 1992;14(2):117-26.
105. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol. 1994;4:214-20.
106. Kaufert P, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas. 1992;14:143-55.
107. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas. 1988;10:317-32.
108. Amick BC 3rd, Kawachi I, Coakley EH, et al. Relationship of job strain and iso-strain to health status in a cohort of women in the United States. Scand J Work Environ Health. 1998;24:54-61.
109. Cheng Y, Kawachi I, Coakley EH, Schwartz J, Colditz G. Association between psychosocial work characteristics and health functioning in American women: prospective study. BMJ. 2000;320:1432-36.
110. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet. Gynecol. 2000;96:351-58.
111. Bromberger JT, Assmann SF, Avis NE, et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003;158:347-56.
112. Bromberger JT, Harlow S, Avis N, Kravitz HM, Cordal A. Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: the Study of Women's Health Across the Nation (SWAN). Am J Public Health. 2004;94:1378-85.
113. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992,14:103-15.
114. Woods NF, Mitchell ES. Anticipating menopause: observations from the Seattle Midlife Women's Health Study. Menopause. 1999;6:167-73.
115. Walters V. Stress, anxiety and depression: women's accounts of their health problems. Soc Sci Med. 1993;36:393-402.
116. Bromberger JT, Matthews KA. A longitudinal study of the effects of pessimism, trait anxiety, and life stress on depressive symptoms in middle-aged women. Psychol Aging. 1996;11:207-13.
117. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K. Hormone therapy and affect. Maturitas. 1979;1:247-59.
118. Baker A, Simpson S, Dawson D. Sleep disruption and mood changes associated with menopause. J Psychosom Res. 1997;43:359-69.
119. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry. 1991;148:844-52.
120. Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurse Health. 1985;8(3):261-68.
121. Berg G, Gottwall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60-62 in Linkoping, Sweden in 1986. Maturitas. 1988;10:193-99.
122. Guthrie J, Dennerstein L, Burger H, Hopper J. Hot flushes, menstrual status and hormone levels in a population-based sample of midlife women. Obstet Gynecol. 1996;88:437-42.
123. Dennerstein L, Brown JB, Gotts G, Morse CA, Farley TM, Pinol A. Menstrual cycle hormonal profiles of women with and without premenstrual syndrome. J Psychosom Obstet Gynaecol. 1993;14:259-68.
124. Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry. 1996;153:1411-17.
125. Carpenter JS, Monahan PO, Azzouz F. Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol. 2004;104(6):1322-26.
126. Morgan M, Cook I, Rapkin A, Leuchter A. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 2007,56:54-60.
127. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry. 2005;66:774-80.
128. Rasgon N, Dunkin J, Fairbanks L, et al. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J Psychiatr Res. 2007;41:338-43.
129. Rasgon NL, Altshuler LL, Fairbanks LA, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry. 2002;63(suppl 7):45-48.
130. Soares CN, Poitras JR, Prouty J, et al. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry. 2003;64:473-79.
131. Joffe H, Groninger H, Soares CN, Nonacs R, Cohen LS. An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. J Womens Health Gend Based Med. 2001;10:999-1004.
132. Amsterdam J, Garcia-Espana F, Fawcett J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999;55(1):11-17.
133. Schneider LS, Small GW, Clary CM. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry. 2001;9:393-99.
134. Nagata H, Nozaki M, Nakano H. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. J Obstet Gynaecol Res. 2005;31:107-14.